BRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE | Zendy

О М Курбачева | Zendy; S A Polner | Zendy; D S Smirnov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

BRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE

Author(s) -

О М Курбачева,

S A Polner,

D S Smirnov

Publication year - 2014

Publication title -

russian journal of allergy

Language(s) - English

Resource type - Journals

eISSN - 2686-682X

pISSN - 1810-8830

DOI - 10.36691/rja499

Subject(s) - asthma , bronchodilator , medicine , anticholinergic , inhaler , anticholinergic agents , tiotropium bromide , bronchodilator agents , intensive care medicine , pathogenesis , anesthesia , lung function , lung

In this article the problems of improving the control of bronchial asthma through optimization of bronchodilator therapy are discussed. Cholinergic mechanisms in the pathogenesis of asthma and the possibilities of use of long-acting m-anticholinergic - tiotropium (via liquid inhaler R espimat) - in the treatment of this disease are shown. Pharmacological properties of bronchodilators are discussed to identify the main groups of patients who need tiotropium therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research